CN101579462A - Medicine for treating prostatauxe and preparation method thereof - Google Patents

Medicine for treating prostatauxe and preparation method thereof Download PDF

Info

Publication number
CN101579462A
CN101579462A CNA200910074548XA CN200910074548A CN101579462A CN 101579462 A CN101579462 A CN 101579462A CN A200910074548X A CNA200910074548X A CN A200910074548XA CN 200910074548 A CN200910074548 A CN 200910074548A CN 101579462 A CN101579462 A CN 101579462A
Authority
CN
China
Prior art keywords
medicine
parts
treatment
prostate hyperplasia
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200910074548XA
Other languages
Chinese (zh)
Inventor
李宏庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA200910074548XA priority Critical patent/CN101579462A/en
Publication of CN101579462A publication Critical patent/CN101579462A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a medicine for treating prostatauxe. Cistanche salsa, dodder, shizandra berry, eucommia bark, achyranthes, sweet potato, Chinese yam, morinda officinalis, cherokee rose, poria, alisma orientale, umbellate pore furgus and dried rhizome of rehmannia are pulverized into fine powder of 100 to 120 meshes, 280 to 300 parts of refined honey are added into every 100 parts of fine powder, and the refined honey and the fine powder are evenly mixed to obtain honeyed pills. The medicine of the invention can ensure abundant heart and lung Qi, abundant liquid, strong muscle, and recovered glandular organ instinct so as to ensure self-extinction of retention of urine. The medicine of the invention treats both superficial and root causes of prostatauxe, has the effective rate of above 90% to various symptoms, has the characteristics of exact effect, quick healing, safety, no toxic and side effect, and no anaphylactic reaction; in addition, the using amount of the medicine is small and the price is low, so that the medicine for treating prostatauxe is likely to be accepted by patients.

Description

A kind of medicine that is used for the treatment of prostate hyperplasia and preparation method thereof
Technical field
The present invention relates to a kind of medicine for the treatment of prostate hyperplasia, particularly relating to a kind of is the medicine of the treatment prostate hyperplasia of crude drug preparation with Chinese medicine.The invention still further relates to the preparation method of this medicine.
Background technology
Prostate hyperplasia is a kind of Senile disease that can't prevent, and most of age of onset were at 50~70 years old, and sickness rate increases progressively gradually with age growth.This is because old back androgen steroid secretion changes, and make prostate body of gland hypertrophy, compressing bladder neck and back urethra, cause urinary tract obstruction, thereby cause symptoms such as urgent micturition, frequent micturition, dysuria, severe patient also acute urinary retention, urinary incontinence, hematuria etc. can occur, the somebody also can cause hydronephrosis, renal failure, acidosis because of urinary tract blocks for a long time, thereby bring out a series of gastrointestinal tract, cardiovascular and spirituality symptom, not only influence old people's quality of life, also can bring spiritual pressure to them.
According to statistics, the male of China more than 50 years old has half to be subjected to the puzzlement of prostatosis at present.At present the method for treatment prostate hyperplasia mainly contains pharmacotherapy, operative therapy, per urethra or rectum and takes the photograph and protect line microwave high-temperature therapy etc.Operative therapy is through per urethram inserting the excision mirror, with the excision of prostatic hyperplastic tissue.Owing to be under the mirror of chamber, to operate, the difficulty of operation technique is bigger, especially the patient who some prostatic hyperplasia is surpassed 100 grams, operation risk is also corresponding bigger, and because the prostate hyperplasia patient mostly is aged patient, because of age factor, the organ aging, in the operation and after the operation accidents such as cerebrovascular and heart disease might take place, also may have complication such as posthemorrhage, epididymitis inflammation, urine retention, urethral stricture, retrograde ejaculation, urinary incontinence, sexual impotence.Per urethra or rectum are taken the photograph and protected line microwave high-temperature therapy is to utilize high temperature to cause the prostata tissue protein denaturation, necrocytosis, atrophy and peeling off, make the urethra that blocks originally unimpeded, it is normal to urinate, need after several weeks, tissue peeled off, just to see to draw effect that treatment and may be followed symptoms such as hemorrhage, calcination, infection often.For weak, to have the inclination, the prostate patients of liver, renal failure etc., pharmacotherapy is the most effective, and the common prostatic medicine of treatment mostly is Western medicine on the market, cures the symptoms, not the disease, and is unwell to diabetes, hypertension, cardiac etc. and takes.
Summary of the invention
The purpose of this invention is to provide a kind of medicine that is used for the treatment of prostate hyperplasia, this Drug therapy is ailing by the various typical case due to the prostate hyperplasia, and safety, cure rate height, relapse rate are low.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Herba Cistanches 10~15 Semen Cuscutae 10~15 Fructus Schisandrae Chinensis 15~20
The Cortex Eucommiae 5~8 Radix Achyranthis Bidentataes 3~5 Rhizoma Dioscoreaes 5~8
Rhizoma Dioscoreae 3~5 Radix Morindae Officinaliss 3~5 Fructus Rosae Laevigatae 3~5
Poria 3~5 Rhizoma Alismatis 3~5 Polyporus 5~8
The Radix Rehmanniae 3~5.
The preferred weight umber of described each component is:
Herba Cistanches 12 Semen Cuscutae 12 Fructus Schisandrae Chinensis 18
The Cortex Eucommiae 6 Radix Achyranthis Bidentataes 4 Rhizoma Dioscoreaes 6
Rhizoma Dioscoreae 4 Radix Morindae Officinaliss 4 Fructus Rosae Laevigatae 4
Poria 4 Rhizoma Alismatis 4 Polyporus 4
The Radix Rehmanniae 4.
Said medicine can be made any dosage form on the pharmaceutics, as tablet, pill, powder, capsule etc., the preferred dosage form of the present invention is a pill.
The concrete preparation method of above-mentioned each component being made medicine of the present invention may further comprise the steps:
Take by weighing above-mentioned parts of medicines by weight, choose most impurity, screen and clean, after drying, mixed powder is broken into 100~120 purpose fine powders, adds 280~300 parts of refined honeys in per 100 parts of powder, and mix homogeneously is made honeyed pill.
Chinese medicine is thought the sick position of prostate hyperplasia at bladder, and is simultaneously relevant with kidney, lung, spleen and three warmers.Pathology is the damp and hot heresy of impression, and in the passing of time going into, or damp-heat in middle-JIAO is not understood the bladder of making a bet; Or kidney moves heat in bladder, and causes damp-heat in the urinary bladder retardance, disturbance in functioning of QI, urinary obstruction; Or internal damage by the excessive seven emotions, causing depression of liver-QI, catharsis is too late, thereby influences the operation of three warmers water liquid, causes logical accent of water channel to be obstructed, and forms the difficulty in urination.And the passages through which vital energy circulates of liver supports few abdomen around external genitals, so stagnate through vapour lock, influences functioning of bladder, also can produce the difficulty in urination.Deficiency of kidney-QI must improve gasification function when tonification profit gold, makes body of gland liquid foot rigidity of soft tissues, and function is restored.In the prescription of the present invention, Herba Cistanches, Fructus Schisandrae Chinensis, Semen Cuscutae, the Cortex Eucommiae, Radix Achyranthis Bidentatae, Rhizoma Dioscoreae, Radix Morindae Officinalis, all the kidney invigorating key medicines of Fructus Rosae Laevigatae improve liver spleen kidney governor vessel instinct.Herba Cistanches has reinforcing the kidney and supporting YANG, loosening bowel to relieve constipation, and the function of hard masses softening and resolving, Radix Morindae Officinalis can kidney-replenishing, benefiting essence-blood, bone and muscle strengthening, wind-damp dispelling, Herba Cistanches is joined Radix Morindae Officinalis, can strengthen the power of warming the kidney to invigorate YANG, the two moisturizes suitable, has to mend fire and do not have the wonderful of dry water, also has the effect of invigorating YANG relieving constipation.Rhizoma Dioscoreae is joined Fructus Schisandrae Chinensis, Radix Morindae Officinalis, Fructus Rosae Laevigatae, Polyporus the kidney invigorating gas, the secret essence of warming the liver, and strong muscle is supporing yang, goes into bladder, lets out the sharp key that stagnates, and it is exhausted to cure mainly deficiency of kidney-QI, the gasification function imbalance.Herba Cistanches is gone into the kidney blood system, moistens its five internal organs, joins the secret essence gate of Semen Cuscutae tonifying five ZANG-organs, the strong spleen fortune of Rhizoma Alismatis, Poria, Rhizoma Dioscoreae, and the sharp key of eliminating dampness by diuresis for Polyporus goes into spleen lung kidney three warps, rises and can fall.All medicine compatibilities, last gas foot, the liquid foot, rigidity of soft tissues, the body of gland instinct is restored, and then the difficulty in urination is from disappearing.
Use medicine of the present invention various prostate hyperplasia are carried out observation of curative effect, wherein treat urine urgency-frequency 250 examples, cure 236 examples, cure rate 94%; Treatment dysuria 200 examples are cured 181 examples, cure rate 91%; Treatment urinary incontinence 200 examples, cure 182 examples, cure rate 91%: treatment acute urinary retention 250 examples, cure 232 examples, cure rate 93%.
Drug therapy prostate hyperplasia treating both the principal and secondary aspects of a disease of the present invention has the characteristics of precise effects and rapid healing, and safely, have no side effect and anaphylaxis, dosage is few, and is cheap, and the patient is easy to accept.
The specific embodiment
Embodiment 1
Get Herba Cistanches 1000g, Semen Cuscutae 1500g, Fructus Schisandrae Chinensis 1500g, Cortex Eucommiae 500g, Radix Achyranthis Bidentatae 300g, Rhizoma Dioscoreae 500g, Rhizoma Dioscoreae 300g, Radix Morindae Officinalis 500g, Fructus Rosae Laevigatae 500g, Poria 300g, Rhizoma Alismatis 500g, Polyporus 800g, Radix Rehmanniae 300g, choose most impurity, screen and clean, after drying, be ground into 100 purpose fine powders, add the 25Kg refined honey, make honeyed pill behind the mix homogeneously, every ball 9g.
Embodiment 2
Get Herba Cistanches 1200g, Semen Cuscutae 1200g, Fructus Schisandrae Chinensis 1800g, Cortex Eucommiae 600g, Radix Achyranthis Bidentatae 400g, Rhizoma Dioscoreae 600g, Rhizoma Dioscoreae 400g, Radix Morindae Officinalis 400g, Fructus Rosae Laevigatae 400g, Poria 400g, Rhizoma Alismatis 400g, Polyporus 600g, Radix Rehmanniae 400g, choose most impurity, screen and clean, after drying, be ground into 120 purpose fine powders, add the 26Kg refined honey, make honeyed pill behind the mix homogeneously, every ball 9g.

Claims (4)

1, a kind of medicine that is used for the treatment of prostate hyperplasia is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Herba Cistanches 10~15 Semen Cuscutae 10~15 Fructus Schisandrae Chinensis 15~20
The Cortex Eucommiae 5~8 Radix Achyranthis Bidentataes 3~5 Rhizoma Dioscoreaes 5~8
Rhizoma Dioscoreae 3~5 Radix Morindae Officinaliss 3~5 Fructus Rosae Laevigatae 3~5
Poria 3~5 Rhizoma Alismatis 3~5 Polyporus 5~8
The Radix Rehmanniae 3~5.
2, the medicine that is used for the treatment of prostate hyperplasia according to claim 1 is characterized in that the ratio of weight and number of described each component is:
Herba Cistanches 12 Semen Cuscutae 12 Fructus Schisandrae Chinensis 18
The Cortex Eucommiae 6 Radix Achyranthis Bidentataes 4 Rhizoma Dioscoreaes 6
Rhizoma Dioscoreae 4 Radix Morindae Officinaliss 4 Fructus Rosae Laevigatae 4
Poria 4 Rhizoma Alismatis 4 Polyporus 4
The Radix Rehmanniae 4.
3, the medicine that is used for the treatment of prostate hyperplasia according to claim 1 is characterized in that described medicine is made pill.
4, the described preparation method that is used for the treatment of the medicine of prostate hyperplasia of claim 3, be to take by weighing described parts of medicines by weight, choose most impurity, screen and clean, after drying, mixed powder is broken into 100~120 purpose fine powders, add 280~300 parts of refined honeys in per 100 parts of powder, mix homogeneously is made honeyed pill.
CNA200910074548XA 2009-06-26 2009-06-26 Medicine for treating prostatauxe and preparation method thereof Pending CN101579462A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA200910074548XA CN101579462A (en) 2009-06-26 2009-06-26 Medicine for treating prostatauxe and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA200910074548XA CN101579462A (en) 2009-06-26 2009-06-26 Medicine for treating prostatauxe and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101579462A true CN101579462A (en) 2009-11-18

Family

ID=41361867

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200910074548XA Pending CN101579462A (en) 2009-06-26 2009-06-26 Medicine for treating prostatauxe and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101579462A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105106696A (en) * 2015-09-07 2015-12-02 江淑芬 Traditional Chinese medicinal composition for treating chronic prostatitis
CN105497427A (en) * 2016-01-23 2016-04-20 李汶峰 Traditional Chinese medicine for treating prostatic hyperplasia
CN111481613A (en) * 2020-06-17 2020-08-04 杭州胡庆余堂药业有限公司 Application of Wubi yam pills in preparation of medicine for treating prostatic hyperplasia

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105106696A (en) * 2015-09-07 2015-12-02 江淑芬 Traditional Chinese medicinal composition for treating chronic prostatitis
CN105497427A (en) * 2016-01-23 2016-04-20 李汶峰 Traditional Chinese medicine for treating prostatic hyperplasia
CN111481613A (en) * 2020-06-17 2020-08-04 杭州胡庆余堂药业有限公司 Application of Wubi yam pills in preparation of medicine for treating prostatic hyperplasia

Similar Documents

Publication Publication Date Title
US7300676B2 (en) Herbal composition for treatment of digestive and urinary disorders
CN101732660A (en) Chinese medicinal preparation for treating prostate disease and preparation method thereof
CN102178889B (en) Chinese medicine preparation for treating gall-stone
CN101862428B (en) Chinese medicament for treating benign prostatic hyperplasia
CN101579462A (en) Medicine for treating prostatauxe and preparation method thereof
CN101732602B (en) Medicament for treating calculi and preparation method thereof
CN104524106A (en) Traditional Chinese medicine preparation for treating prostatitis and prostatic hyperplasia and preparation method thereof
CN101518603A (en) Traditional Chinese medical composition used for treating prostatic hyperplasia and preparation method thereof
CN104069372B (en) A kind of renal calculus Paishi Tang and instructions of taking thereof
CN106492075A (en) A kind of treat Chinese medicine composition of hyperplasia of prostate and preparation method thereof
CN101700346A (en) Formulation of oral traditional Chinese medicine for treating ureteral calculi
CN104587126A (en) Traditional Chinese medicine powder for treating stomach disease
CN101024006B (en) Chinese medicine for treating gallstones
CN114558090B (en) Medicine for treating benign prostatic hyperplasia
CN103316325B (en) Traditional Chinese medicine preparation for treating ovarian cyst
CN101461912A (en) Orienting Chinese medicine-releasing preparation for treating colonitis and preparation method thereof
CN108261493A (en) A kind of Cortex Phellodendri rhizoma anemarrhenae clearing heat and promoting diuresis ball and preparation method thereof
CN103007229B (en) Medicine for treating neurogenic bladder
CN112439010B (en) Traditional Chinese medicine composition for tonifying qi, tonifying kidney and strengthening and shrinking and application thereof
CN101732624A (en) Formula for treating ureteral calculi and preparation method thereof
CN104491312A (en) Use of tradtional Chinese medicine preparation in preparing medicines for treating prostatitis and prostatauxe
CN105998958A (en) Medicine for treating pancreatic cancer and preparation method thereof
CN101229238A (en) Chinese traditional medicine preparation for treating prostate disease
CN105902847A (en) Traditional Chinese medicinal composition for treating prostatoplasia
CN116509977A (en) A Chinese medicinal composition for treating calculus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20091118